Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation
- PMID: 36708812
- DOI: 10.1016/j.jhep.2023.01.010
Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation
Abstract
Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state due to a parallel decline in both pro- and anti-haemostatic pathways. However, this rebalanced haemostatic state is highly susceptible to perturbations and may easily tilt towards hypocoagulability and bleeding. Acute kidney injury, bacterial infections and sepsis, and progression from acute decompensation to acute-on-chronic liver failure are associated with additional alterations of specific haemostatic pathways and a higher risk of bleeding. Unfortunately, there is no single laboratory method that can accurately stratify an individual patient's bleeding risk and guide pre-procedural prophylaxis. A better understanding of haemostatic alterations during acute illness would lead to more rational and individualised management of hospitalised patients with decompensated cirrhosis. This review will outline the latest findings on haemostatic alterations driven by acute kidney injury, bacterial infections/sepsis, and acute-on-chronic liver failure in these difficult-to-treat patients and provide evidence supporting more tailored management of bleeding risk.
Keywords: bleeding; coagulation; fibrinolysis; platelets; thrombosis.
Copyright © 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Unravelling the coagulation paradox in liver cirrhosis: challenges and insights.Acta Clin Belg. 2024 Dec;79(6):451-461. doi: 10.1080/17843286.2025.2469906. Epub 2025 Feb 21. Acta Clin Belg. 2024. PMID: 39981790 Review.
-
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.J Hepatol. 2023 Feb;78(2):301-311. doi: 10.1016/j.jhep.2022.09.005. Epub 2022 Sep 21. J Hepatol. 2023. PMID: 36150575
-
Haemostatic alterations and management of haemostasis in patients with cirrhosis.J Hepatol. 2022 Jun;76(6):1291-1305. doi: 10.1016/j.jhep.2021.11.004. J Hepatol. 2022. PMID: 35589251 Review.
-
Pathophysiology and management of bleeding and thrombosis in patients with liver disease.Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):79-88. doi: 10.1111/ijlh.13856. Epub 2022 Apr 21. Int J Lab Hematol. 2022. PMID: 35446468 Free PMC article. Review.
-
[Coagulation disorders in liver cirrhosis - Diagnostics and management].Dtsch Med Wochenschr. 2024 Aug;149(16):963-973. doi: 10.1055/a-2330-3564. Epub 2024 Aug 2. Dtsch Med Wochenschr. 2024. PMID: 39094601 Review. German.
Cited by
-
Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD.JHEP Rep. 2023 Oct 12;6(1):100934. doi: 10.1016/j.jhepr.2023.100934. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38074505 Free PMC article.
-
Development of a nomogram for the prediction of acute kidney injury after liver transplantation: a model based on clinical parameters and postoperative cystatin C level.Ann Med. 2023;55(2):2259410. doi: 10.1080/07853890.2023.2259410. Epub 2023 Sep 21. Ann Med. 2023. PMID: 37734410 Free PMC article.
-
Bleeding and Thrombosis in Patients With Cirrhosis: What's New?Hemasphere. 2023 May 23;7(6):e886. doi: 10.1097/HS9.0000000000000886. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37234821 Free PMC article. No abstract available.
-
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma.United European Gastroenterol J. 2025 Jun;13(5):728-737. doi: 10.1002/ueg2.12758. Epub 2025 Jan 23. United European Gastroenterol J. 2025. PMID: 39846484 Free PMC article.
-
How to manage hemostasis in patients with liver disease during interventions.Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):274-280. doi: 10.1182/hematology.2023000480. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066857 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical